Science

2023

PSMA Radioligand Therapy in Prostate Cancer: Where Are We and Where Are We Heading?

Almeida LS, de Camargo Etchebehere ECS, Megías IG, Calapaquí Terán AK, Hadaschik B, Colletti PM, Herrmann K, Giammarile F, Delgado Bolton RC

Journal: Clinical Nuclear Medicine

Année: nov 2023

 

https://doi.org/10.1097/RLU.0000000000004919

. ExacTrac X-Ray 6D Imaging During Stereotactic Body Radiation Therapy of Spinal and Nonspinal Metastases.

Hadj Henni A, Gensanne D, Bulot G, Roge M, Mallet R, Colard E, Daras M, Hanzen C, Thureau S

Journal: Technology in Cancer Research & Treatment

Année: oct 2023

Volume: 22

 

https://doi.org/10.1177/15330338231210786

Clinical trials that will change practices: News in palliative radiotherapy

Agnoux E, Renan A, Faivre JC

Journal: Cancer/Radiothérapie 

Année: dec 2023

Volume: 27, Issue 8

Pages: 746-753

https://doi.org/10.1016/j.canrad.2023.08.004

Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor

Turpin A, Delliaux C, Parent P, Chevalier H, Escudero-Iriarte C, Bonardi F, Vanpouille N, Flourens A, Querol J, Carnot A, Leroy X, Herranz N, Lanel T, Villers A, Olivier J, Touzet H, de Launoit Y, Tian TV, Duterque-Coquillaud M.

Journal: British Journal of Cancer

Année: Oct 2023

 

https://doi.org/10.1038/s41416-023-02449-x

Stereotactic body radiation therapy for bone oligometastases

Naessens C, Chamois J, Supiot S, Faivre JC, Arnaud A, Thureau S

Journal: Cancer/Radiothérapie 

Année: oct 2023

 

https://doi.org/10.1016/j.canrad.2023.04.006

Technical report: liquid overlay technique allows the generation of homogeneous osteosarcoma, glioblastoma, lung and prostate adenocarcinoma spheroids that can be used for drug cytotoxicity measurements

Jubelin C, Muñoz-Garcia J, Cochonneau D, Ollivier E, Vallette F, Heymann MF, Oliver L, Heymann D

Journal: Frontiers in Bioengineering and Biotechnology 

Année: oct 2023

Volume: 11

 

https://doi.org/10.3389/fbioe.2023.1260049

Drug-tolerant persister cells in cancer: the cutting edges and future directions

Pu Y, Li L, Peng H, Liu L, Heymann D, Robert C, Vallette F, Shen S

Journal: Nature Reviews Clinical Oncology 

Année: sept 2023

Volume: 20

Pages: 799-813

https://doi.org/10.1038/s41571-023-00815-5

Strategy planning for turbulent times in nuclear medicine: Time to begin at the beginning?

Allie R, Kayani I, Gnanasegaran G, Vinjamuri S, Chiti A, Paez D, Giammarile F, Herrmann K, Bomanji J.

Journal: European Journal of Nuclear Medicine and Molecular imaging 

Année: aug 2023

Volume: 51

Pages: 12-19

https://doi.org/10.1007/s00259-023-06379-x